Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMEKIZUMAB vs BINIMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIMEKIZUMAB vs BINIMETINIB: Safety Overview

Metric BIMEKIZUMAB BINIMETINIB
Total FAERS Reports 2,459 6,914
Deaths Reported 31 1,069
Death Rate 1.3% 15.5%
Hospitalizations 565 1,990
Average Patient Age 52.9 yrs 63.0 yrs
% Female Patients 59.9% 47.7%
FDA Approval Date N/A Jun 27, 2018
Manufacturer UCB, Inc. Array BioPharma Inc.
Route SUBCUTANEOUS ORAL
Marketing Status N/A Prescription